Multiple Less Common Genetic Variants Explain the Association of the Cholesteryl Ester Transfer Protein Gene With Coronary Artery Disease

Journal of the American College of Cardiology

Volumn 49, Issue 20, 2007, Pages 2053-2060

  Horne, Benjamin D ^a,b   Camp, Nicola J ^b,c   Anderson, Jeffrey L ^a,b   Mower, Chrissa P ^a   Clarke, Jessica L ^a   Kolek, Matthew J ^a   Carlquist, John F ^a,b  

^a LDS HOSPITAL   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c Genetic Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HUMAN; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT;

CASE-CONTROL STUDIES; CHOLESTEROL ESTER TRANSFER PROTEINS; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REGISTRIES;

EID: 34248335497     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.02.039     Document Type: Article

References (36)

1. Marenberg M.E., Risch N., Berkman L.F., Floderus B., and de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330 (1994) 1041-1046
2. Zdravkovic S., Wienke A., Pedersen N.L., et al. Heritability of death from coronary heart disease: a 36-year follow-up of 20,966 Swedish twins. J Intern Med 252 (2002) 247-254
3. Hopkins P.N., Hunt S.C., and Wu L.L. Family history and genetic factors. In: Wong N.D., Black H.R., and Gardin J.M. (Eds). Preventive Cardiology: A Practical Approach (2005), McGraw-Hill, New York. NY 92-148
4. Cohen J.C., Kiss R.S., Pertsemlidis A., et al. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305 (2004) 869-872
5. Cohen J.C., Boerwinkle E., Mosley Jr. T.H., and Hobbs H.H. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 354 (2006) 1264-1272
6. Tall A. Plasma lipid transfer proteins. Ann Rev Biochem 64 (1999) 235-257
7. Thompson J.F., Lira M.E., Durham L.K., Clark R.W., Bamberger M.J., and Milos P.M. Polymorphisms in the CETP gene and association with CETP mass and HDL levels. Atherosclerosis 167 (2003) 195-204
8. Klerkx A.H.E.M., Tanck M.W.T., Kastelein J.J.P., et al. Haplotype analysis of the CETP gene: not TaqIB, but the closely linked -629C→A polymorphism and a novel promoter variant are independently associated with CETP concentration. Hum Mol Genet 12 (2003) 111-123
9. Anderson J.L., and Carlquist J.F. Genetic polymorphisms of hepatic lipase and cholesteryl ester transfer protein, intermediate phenotypes, and coronary risk: do they add up yet?. J Am Coll Cardiol 41 (2003) 1990-1993
10. Boekholdt S.M., Kuivenhoven J.A., Wareham N.J., et al. Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women. Circulation 110 (2004) 1418-1423
11. Freeman D.J., Samani N.J., Wilson V., et al. A polymorphism of the cholesteryl ester transfer protein gene predicts cardiovascular events in non-smokers in the West of Scotland Coronary Prevention Study. Eur Heart J 24 (2003) 1833-1842
12. Thompson J.F., Durham L.K., Lira M.E., Shear C., and Milos P.M. CETP polymorphisms associated with HDL cholesterol may differ from those associated with cardiovascular disease. Atherosclerosis 181 (2005) 45-53
13. Agerholm-Larsen B., Nordestgaard B.G., Steffensen R., Jensen G., and Tybjaerg-Hansen A. Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene. Circulation 101 (2000) 1907-1912
14. Agerholm-Larsen B., Tybjaerg-Hansen A., Schnohr P., Steffensen R., and Nordestgaard B.G. Common cholesteryl ester transfer protein mutations, decreased HDL cholesterol, and possible decreased risk of ischemic heart disease. Circulation 102 (2000) 2197-2203
15. Boekholdt S.M., Sacks F.M., Jukema J.W., et al. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation 111 (2005) 278-287
16. Brousseau M.E., Schaefer E.J., Wolfe M.L., et al. Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. N Engl J Med 350 (2004) 1505-1515
17. Berenson A. End of Drug Trial is a Big Loss for Pfizer (2006) New York Times. December 4
18. Johnson G.C., Esposito L., Barratt B.J., et al. Haplotype tagging for the identification of common disease genes. Nat Genet 29 (2001) 233-237
19. Horne B.D., and Camp N.J. Principal component analysis for selection of optimal SNP-sets that capture intragenic genetic variation. Genet Epidemiol 26 (2004) 11-21
20. Horne B.D., Carlquist J.F., Cannon-Albright L.A., et al. High-resolution characterization of linkage disequilibrium structure and selection of tagging SNPs for the cholesteryl ester transfer protein. Ann Hum Genet 70 (2006) 524-534
21. Anderson J.L., Carlquist J.F., Horne B.D., and Muhlestein J.B. Cardiovascular pharmacogenomics: current status, future prospects. J Cardiovasc Pharmacol Ther 8 (2003) 71-83
22. Topol E.J., Smith J., Plow E.F., and Wang Q.K. Genetic susceptibility to myocardial infarction and coronary artery disease. Hum Mol Genet 15 (2006) R117-R123
23. Whiting B.M., Anderson J.L., Muhlestein J.B., et al. Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery disease. Am Heart J 150 (2005) 243-250
24. Ioannidis J.P., Ntzani E.E., Trikalinos T.A., and Contopoulos-Ioannidis D.G. Replication validity of genetic association studies. Nat Genet 29 (2001) 306-309
25. Hegele R.A. SNP judgments and freedom of association. Arterioscler Thromb Vasc Biol 22 (2002) 1058-1061
26. Keavney B., McKenzie C., Parish S., et al., International Studies of Infarct Survival (ISIS) Collaborators. Large-scale test of hypothesised association between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. Lancet 355 (2000) 434-442
27. Frisdal E., Klerkx A.H., Le Goff W., et al. Functional interaction between -629C/A, -971G/A and -1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study. Hum Mol Genet 14 (2005) 2607-2618
28. The International HapMap Consortium. A haplotype map of the human genome. Nature 437 (2005) 1299-1320
29. Lander E.S. The new genomics: global views of biology. Science 274 (1996) 536-539
30. Twells R.C.J., Mein C.A., Phillips M.S., et al. Haplotype structure, LD blocks, and uneven recombination within the LRP5 gene. Genome Res 13 (2003) 845-855
31. Weiss K.M., and Terwilliger J.D. How many diseases does it take to map a gene with SNPs?. Nat Genet 26 (2000) 151-157
32. Camp N.J., Swensen J., Horne B.D., et al. Characterization of linkage disequilibrium structure, mutation history, and tagging SNPs, and their use in association analyses: ELAC2 and familial early-onset prostate cancer. Genet Epidemiol 28 (2005) 232-243
33. Terwillinger J.D., and Hiekkalinna T. An utter refutation of the "Fundamental Theorem of the HapMap.". Eur J Hum Genet 14 (2006) 426-437
34. Kuivenhoven J.A., de Knijff P., Boer J.M., et al. Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels. Arterioscler Thromb Vasc Biol 17 (1997) 560-568
35. Carlquist J.F., Muhlestein J.B., Molhuizen H.O.F., et al. The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease. Am Heart J 146 (2003) 1007-1014
36. Horne B.D., Anderson J.L., Carlquist J.F., et al. Generating genetic risk scores from intermediate phenotypes for use in association studies of clinically significant endpoints. Ann Hum Genet 69 (2005) 176-186